Muranishi, K.; Kinoshita, M.; Inoue, K.; Ohara, J.; Mihara, T.; Sudo, K.; Ishii, K.J.; Sawa, T.; Ishikura, H.
Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine. Vaccines 2024, 12, 5.
https://doi.org/10.3390/vaccines12010005
AMA Style
Muranishi K, Kinoshita M, Inoue K, Ohara J, Mihara T, Sudo K, Ishii KJ, Sawa T, Ishikura H.
Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine. Vaccines. 2024; 12(1):5.
https://doi.org/10.3390/vaccines12010005
Chicago/Turabian Style
Muranishi, Kentaro, Mao Kinoshita, Keita Inoue, Junya Ohara, Toshihito Mihara, Kazuki Sudo, Ken J. Ishii, Teiji Sawa, and Hiroyasu Ishikura.
2024. "Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine" Vaccines 12, no. 1: 5.
https://doi.org/10.3390/vaccines12010005
APA Style
Muranishi, K., Kinoshita, M., Inoue, K., Ohara, J., Mihara, T., Sudo, K., Ishii, K. J., Sawa, T., & Ishikura, H.
(2024). Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine. Vaccines, 12(1), 5.
https://doi.org/10.3390/vaccines12010005
